Hamm & Wittkopp patent opposition analysis

The comprehensive analysis of Hamm & Wittkopp opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Hamm & Wittkopp

Patent NumberTitleApplicantOpposition DateOpposition Company
Manufacture Of A Crystalline Pharmaceutical ProductORIONJan 8, 2026HAMM & WITTKOPP
Formulation For Inhibiting Formation Of 5-Ht 2B Agonists And Methods Of Using SameZOGENIXJan 6, 2026ALFRED E TIEFENBACHER
Crystal Form Of Ozanimod, Crystal Form Of Hydrochloride Thereof, And Preparation Method ThereforRECEPTOSDec 19, 2025SYNTHON
Combinations Of Cabozantinib And Atezolizumab To Treat CancerEXELIXISDec 19, 2025STADA ARZNEIMITTEL
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEDec 19, 2025HAMM & WITTKOPP
Solid State Forms Of Ixazomib CitrateASSIA CHEMICAL INDUSTRIESDec 19, 2025HAMM & WITTKOPP
Gas Diffusion Electrode Substrate, Method For Producing Same, Gas Diffusion Electrode, Membrane-Electrode Assembly, And Solid Polymer Fuel CellTORAY INDUSTRIESDec 16, 2025CARL FREUDENBERG
Fenfluramine Compositions And Methods Of Preparing The SameZOGENIXOct 29, 2025ALFRED E TIEFENBACHER
Nalmefene For Reduction Of Alcohol Consumption In Specific Target PopulationsH LUNDBECKOct 27, 2025ALFRED E TIEFENBACHER
Methods For Treating Hypertrophic CardiomyopathyCYTOKINETICSOct 14, 2025SYNTHON